CEO Joaquin Duato Files to Sell $32.2M in J&J Shares
JNJ sits 51% above its 52-week low of $172.695 on light trading volume (0.2× avg).
Summary
J&J CEO Joaquin Duato plans to sell $32.2 million in shares, adding to $12.5 million sold last week.
Key Events · Ownership and Investor Activity · JNJ
-
CEO Files to Sell $32.2M
Joaquin Duato filed Form 144 to sell 123,291 shares worth approximately $32.2 million on August 13, 2026.
-
Shares From Option Exercise
The shares were acquired the same day via stock option exercise, indicating a cash-out of equity compensation.
-
Recent Selling Pattern
Duato sold 48,480 shares for $12.5 million on August 5, 2026, just eight days before this filing.
-
Trading Near 52-Week High
The stock trades at $261.49, near its 52-week high of $274.90, providing a favorable window for insider sales.
Analysis · JNJ · Life Sciences
CEO Joaquin Duato filed a Form 144 to sell 123,291 shares worth approximately $32.2 million, acquired the same day via stock option exercise. This follows a $12.5 million sale just eight days earlier. While the dollar amount is modest relative to J&J's $630 billion market cap, the CEO's repeated selling near a 52-week high is a notable insider signal.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 29.4% of the 1386 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, JNJ was trading at $261.49 on NYSE in the Life Sciences sector, with a market capitalization of approximately $630.2B. The 52-week trading range was $172.70 to $274.90. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.